SPRB - Spruce Biosciences Inc
Previous close
0.4645
0 0%
Share volume: 148,486
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.46
0.00
0.00%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
-2.66%
1 Month
-11.30%
3 Months
-35.78%
6 Months
-91.35%
1 Year
-79.11%
2 Year
-78.68%
Key data
Stock price
$0.46
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.41 - $5.95
52 WEEK CHANGE
-$0.79
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO:
Region: US
Website: sprucebiosciences.com
Employees: 31
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: sprucebiosciences.com
Employees: 31
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
spruce biosciences is a clinical stage biopharmaceutical company focused on developing novel therapies for rare diseases affecting the endocrine system.
Recent news